跳至主要内容
临床试验/NCT01476267
NCT01476267已完成1 期

An Open Label, Single Centre Study to Investigate the Metabolic Profile of Dalcetrapib After a Single Oral Dose in Healthy Male Subjects

Hoffmann-La Roche0 个研究点目标入组 6 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
6
主要终点
Metabolic Profile: Percentage of Free Thiophenol M1 in the Blood Plasma

研究概览

简要总结

This single center, open-label, non-randomized, one-treatment, one-period study will evaluate the metabolic profile and the safety of a single oral radiolabeled dose of dalcetrapib in male healthy volunteers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male subjects, 45 to 65 years of age inclusive
  • Body mass index (BMI) between 18 and 32 kg/m2 inclusive

排除标准

  • Any concomitant disease or ongoing condition that in the investigator's opinion could interfere with the study or could pose an unacceptable risk to the subject
  • Clinically significant abnormal laboratory values
  • Infrequent bowel movements (e.g. less than one movement per 24 h on average)
  • An intent to father children within 3 months of dosing
  • Any external or internal radiotherapy with open (nuclear medicine) or sealed sources (brachy therapy)
  • External irradiation (radiological examination) or internal radiation (diagnostic nuclear medicine procedure) within one year before study drug dosing; dental radiography and plain X-rays of the extremities are allowed before dosing

研究组 & 干预措施

Single Arm

Experimental

干预措施: dalcetrapib (Drug)

结局指标

主要结局

Metabolic Profile: Percentage of Free Thiophenol M1 in the Blood Plasma

时间窗: up to Day 5

次要结局

  • Correlation of Metabolic Profile With Enzyme/Transporter Genotypes(approximately 3 months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验